BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27197300)

  • 1. Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast Conditions.
    Adams DL; Adams DK; Alpaugh RK; Cristofanilli M; Martin SS; Chumsri S; Tang CM; Marks JR
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1037-42. PubMed ID: 27197300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic values of cancer associated macrophage-like cells (CAML) enumeration in metastatic breast cancer.
    Mu Z; Wang C; Ye Z; Rossi G; Sun C; Li L; Zhu Z; Yang H; Cristofanilli M
    Breast Cancer Res Treat; 2017 Oct; 165(3):733-741. PubMed ID: 28687903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-based biopsies-clinical utility beyond circulating tumor cells.
    Tang CM; Zhu P; Li S; Makarova OV; Amstutz PT; Adams DL
    Cytometry A; 2018 Dec; 93(12):1246-1250. PubMed ID: 30369050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of peripheral blood M2/M1 like monocyte ratio in the diagnosis of breast cancer and the differentiation between benign and malignant breast tumors.
    Fadhil M; Abdul-Rasheed O; Al-Naqqash M
    Acta Biochim Pol; 2019 Dec; 66(4):437-443. PubMed ID: 31794652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta 2-Adrenergic Receptor in Circulating Cancer-Associated Cells Predicts for Increases in Stromal Macrophages in Circulation and Patient Survival in Metastatic Breast Cancer.
    Gardner KP; Cristofanilli M; Chumsri S; Lapidus R; Tang CM; Raghavakaimal A; Adams DL
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential Tracking of PD-L1 Expression and RAD50 Induction in Circulating Tumor and Stromal Cells of Lung Cancer Patients Undergoing Radiotherapy.
    Adams DL; Adams DK; He J; Kalhor N; Zhang M; Xu T; Gao H; Reuben JM; Qiao Y; Komaki R; Liao Z; Edelman MJ; Tang CM; Lin SH
    Clin Cancer Res; 2017 Oct; 23(19):5948-5958. PubMed ID: 28679765
    [No Abstract]   [Full Text] [Related]  

  • 7. Early detection of breast cancer using total biochemical analysis of peripheral blood components: a preliminary study.
    Zelig U; Barlev E; Bar O; Gross I; Flomen F; Mordechai S; Kapelushnik J; Nathan I; Kashtan H; Wasserberg N; Madhala-Givon O
    BMC Cancer; 2015 May; 15():408. PubMed ID: 25975566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
    Yie SM; Luo B; Ye NY; Xie K; Ye SR
    Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Morphological Characterization of Features of Circulating Cancer-Associated Macrophage-like Cells (CAMLs) in Endometrial Cancers.
    Sulaiman R; De P; Aske JC; Lin X; Dale A; Vaselaar E; Ageton C; Gaster K; Espaillat LR; Starks D; Dey N
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
    Chen X; Chen H; Dai M; Ai J; Li Y; Mahon B; Dai S; Deng Y
    Oncotarget; 2016 Jun; 7(24):36622-36631. PubMed ID: 27153558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating miRNAs revealed as surrogate molecular signatures for the early detection of breast cancer.
    Mishra S; Srivastava AK; Suman S; Kumar V; Shukla Y
    Cancer Lett; 2015 Dec; 369(1):67-75. PubMed ID: 26276721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Filtration and Analysis of Circulating Cancer Associated Cells from the Blood of Cancer Patients.
    Tang CM; Zhu P; Li S; Makarova OV; Amstutz PT; Adams DL
    Methods Mol Biol; 2017; 1572():511-524. PubMed ID: 28299708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction.
    de Cremoux P; Extra JM; Denis MG; Pierga JY; Bourstyn E; Nos C; Clough KB; Boudou E; Martin EC; Müller A; Pouillart P; Magdelénat H
    Clin Cancer Res; 2000 Aug; 6(8):3117-22. PubMed ID: 10955792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer associated macrophage-like cells and prognosis of esophageal cancer after chemoradiation therapy.
    Gironda DJ; Adams DL; He J; Xu T; Gao H; Qiao Y; Komaki R; Reuben JM; Liao Z; Blum-Murphy M; Hofstetter WL; Tang CM; Lin SH
    J Transl Med; 2020 Nov; 18(1):413. PubMed ID: 33148307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-associated circulating microparticles: A novel liquid biopsy tool for screening and therapy monitoring of colorectal carcinoma and other epithelial neoplasia.
    Willms A; Müller C; Julich H; Klein N; Schwab R; Güsgen C; Richardsen I; Schaaf S; Krawczyk M; Krawczyk M; Lammert F; Schuppan D; Lukacs-Kornek V; Kornek M
    Oncotarget; 2016 May; 7(21):30867-75. PubMed ID: 27127176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating giant macrophages as a potential biomarker of solid tumors.
    Adams DL; Martin SS; Alpaugh RK; Charpentier M; Tsai S; Bergan RC; Ogden IM; Catalona W; Chumsri S; Tang CM; Cristofanilli M
    Proc Natl Acad Sci U S A; 2014 Mar; 111(9):3514-9. PubMed ID: 24550495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and analysis of the NCI-EDRN breast cancer reference set for circulating markers of disease.
    Marks JR; Anderson KS; Engstrom P; Godwin AK; Esserman LJ; Longton G; Iversen ES; Mathew A; Patriotis C; Pepe MS
    Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):435-41. PubMed ID: 25471344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of circulating cell-free DNA analysis as a diagnostic tool for breast cancer: a meta-analysis.
    Lin Z; Neiswender J; Fang B; Ma X; Zhang J; Hu X
    Oncotarget; 2017 Apr; 8(16):26625-26636. PubMed ID: 28460452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine needle aspiration may shed breast cells into peripheral blood as determined by RT-PCR.
    Hu XC; Chow LW
    Oncology; 2000 Sep; 59(3):217-22. PubMed ID: 11053989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
    Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
    Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.